Enlaces

http://www.islamhoy.org/principal/Novedades/ayunodiabetes.htm

http://www.factbook.net/muslim_pop.php

Referencias

1. Al-Arouj M, Bougerra R, Buse J, et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 28:2305-2311,2005.
2. An analysis of the world Muslim population by country/region [article online]. Available at http://www.factbook.net/muslim_pop.php. Accessed 4 Enero 2008
3. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053, 2004[Abstract/Free Full Text]
4. Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A, the EPIDIAR Study Group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27:2306–2311, 2004[Abstract/Free Full Text]
5. International Meeting on Diabetes and Ramadan Recommendations: Edition of the Hassan II Foundation for Scientific and Medical Research on Ramadan. Casablanca, Morocco, FRSMR, 1995.
6. Sari R, Balci MK, Akbas SH, Avci B: The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 30:169–177, 2004[Medline]
7. Mafauzy M: Repaglinide versus glibenclamide treatment of type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract 58:45–53, 2002[Medline]
8. Akram J, De Verga V: Insulin lispro in the treatment of diabetes during the fasting month of Ramadan. Diabet Med 16:861–866, 1999[Medline]
9. Akbani MF, Saleem M, Gadit WU, Ahmed M, Basit A, Malik RA: Fasting and feasting safely during Ramadan in the diabetic patient. Pract Diab Int 22:100–104, 2005